With $29.5 million in total funding, the company has developed the world's leading spatial biology platform, designed for breakthroughs in drug development, clinical diagnostics, agriculture, and food ...
PRINCETON, N.J.--(BUSINESS WIRE)--Kanvas Biosciences, a full-stack spatial biology company, today announced results from a clinical trial of fecal microbiota transplantation (FMT) and anti-PD-1 ...
PRINCETON, N.J., June 22, 2023 /PRNewswire/ -- Kanvas Biosciences, the leader in microbiome mapping technology, announced today a $12M Pre-Series A funding round. The investment will be used to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results